iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Reaches New 12-Month High – Here’s Why

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $87.12 and last traded at $87.0440, with a volume of 52901 shares traded. The stock had previously closed at $85.85.

iShares U.S. Pharmaceuticals ETF Price Performance

The stock has a market capitalization of $984.23 million, a PE ratio of 17.75 and a beta of 0.54. The firm has a fifty day moving average price of $84.38 and a two-hundred day moving average price of $75.80.

Institutional Trading of iShares U.S. Pharmaceuticals ETF

Several institutional investors and hedge funds have recently made changes to their positions in IHE. Harbor Asset Planning Inc. purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF during the second quarter valued at $27,000. Mather Group LLC. purchased a new position in iShares U.S. Pharmaceuticals ETF in the 3rd quarter worth about $38,000. Ameriflex Group Inc. lifted its holdings in iShares U.S. Pharmaceuticals ETF by 100.0% during the 3rd quarter. Ameriflex Group Inc. now owns 582 shares of the company’s stock valued at $42,000 after buying an additional 291 shares in the last quarter. National Bank of Canada FI lifted its holdings in iShares U.S. Pharmaceuticals ETF by 42.7% during the 3rd quarter. National Bank of Canada FI now owns 585 shares of the company’s stock valued at $42,000 after buying an additional 175 shares in the last quarter. Finally, CX Institutional boosted its position in iShares U.S. Pharmaceuticals ETF by 2,665.5% in the 3rd quarter. CX Institutional now owns 802 shares of the company’s stock valued at $58,000 after buying an additional 773 shares during the period.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.